Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
A new market beckons for Alzheimer’s blood tests
A new market beckons for Alzheimer’s blood tests
EP Vantage
Alzheimer's disease
diagnostics
donanemab
Eli Lilly
Biogen
Quanterix
Flag link:
Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab
Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab
Reuters
Eli Lilly
FDA
antibodies
COVID-19
bamlanivimab
Flag link:
Eli Lilly axes 163 Dermira staffers, shutters Menlo Park site as it closes in around Dupixent rival lebrikizumab
Eli Lilly axes 163 Dermira staffers, shutters Menlo Park site as it closes in around Dupixent rival lebrikizumab
Endpoints
Eli Lilly
Dermira
Qbexza
layoffs
Flag link:
Lilly, Arch join Deerfield in backing new gene therapy biotech Jaguar
Lilly, Arch join Deerfield in backing new gene therapy biotech Jaguar
BioPharma Dive
Jaguar Gene Therapy
funding
Eli Lilly
Arch Venture Partners
Flag link:
With variants spreading, Eli Lilly cuts solo COVID-19 antibody out of its U.S. supply deal
With variants spreading, Eli Lilly cuts solo COVID-19 antibody out of its U.S. supply deal
Fierce Pharma
Eli Lilly
COVID-19
antibodies
bamlanivimab-etesevimab
Flag link:
5 takeaways from AACR, one of the year's top meetings on cancer drugs
5 takeaways from AACR, one of the year's top meetings on cancer drugs
BioPharma Dive
AACR
CAR-T
Merck
Roche
Sanofi
Synthorx
Eli Lilly
Bristol Myers Squibb
Flag link:
Pharma's pandemic reputation gains score a 'most-improved' medal in annual ranking
Pharma's pandemic reputation gains score a 'most-improved' medal in annual ranking
Fierce Pharma
reputation
pharma industry
Sanofi
Novo Nordisk
Roche
Eli Lilly
Bristol Myers Squibb
Flag link:
Lilly gene-targeted drug shows potential for use across cancers
Lilly gene-targeted drug shows potential for use across cancers
BioPharma Dive
Eli Lilly
AAACR
Retevmo
cancer
clinical trials
Flag link:
Lilly claims promising finding in failed study of COVID-19 drug
Lilly claims promising finding in failed study of COVID-19 drug
BioPharma Dive
Eli Lilly
Incyte
COVID-19
baricitinib
Flag link:
Series of JAK inhibitor delays may signal an upcoming FDA adcomm
Series of JAK inhibitor delays may signal an upcoming FDA adcomm
Endpoints
FDA
JAK inhibitors
AbbVie
Rinvoq
Pfizer
Xeljanz
Eli Lilly
olumiant
Flag link:
FDA pushes eczema decision for Eli Lilly's Olumiant, Pfizer's abrocitinib back 3 months — raising more questions for the JAK class
FDA pushes eczema decision for Eli Lilly's Olumiant, Pfizer's abrocitinib back 3 months — raising more questions for the JAK class
Endpoints
FDA
JAK inhibitors
Eli Lilly
olumiant
Pfizer
abrocitinib
eczema
Flag link:
Eli Lilly, GlaxoSmithKline-Vir release positive but difficult-to-interpret combo antibody data
Eli Lilly, GlaxoSmithKline-Vir release positive but difficult-to-interpret combo antibody data
Endpoints
Eli Lilly
GSK
Vir Biotechnology
VIR-7831
bamlanivimab
clinical trials
COVID-19
Flag link:
Ex-lobbyist sues Eli Lilly alleging sexual discrimination, harassment
Ex-lobbyist sues Eli Lilly alleging sexual discrimination, harassment
Reuters
Eli Lilly
gender discrimination
Flag link:
FDA Advisory Committee Raises Objections to Pfizer and Eli Lilly’s Tanezumab
FDA Advisory Committee Raises Objections to Pfizer and Eli Lilly’s Tanezumab
BioSpace
FDA
advisory panels
Pfizer
Eli Lilly
tanezumab
osteoarthritis
Flag link:
Will Another Alzheimer's Disease Drug Bite the Dust After Lilly's Latest Results?
Will Another Alzheimer's Disease Drug Bite the Dust After Lilly's Latest Results?
Motley Fool
Eli Lilly
Alzheimer's disease
donanemab
Flag link:
Pfizer has run 41 trials over 15 years for tanezumab. As adcomm nears, the FDA remains unimpressed — and more than a little worried
Pfizer has run 41 trials over 15 years for tanezumab. As adcomm nears, the FDA remains unimpressed — and more than a little worried
Endpoints
Pfizer
Eli Lilly
tanezumab
FDA
advisory panels
osteoarthritis
Flag link:
Eli Lilly’s Covid-19 drug bamlanivimab is no longer distributed in 3 states because of a variant, Woodcock says
Eli Lilly’s Covid-19 drug bamlanivimab is no longer distributed in 3 states because of a variant, Woodcock says
Endpoints
Eli Lilly
COVID-19
bamlanivimab
COVID-19 variants
Flag link:
Court win for Eli Lilly halts HHS’s drug discount rule
Court win for Eli Lilly halts HHS’s drug discount rule
Endpoints
HHS
Eli Lilly
340B
Flag link:
4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package
4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package
Motley Fool
stimulus
pharma stocks
Eli Lilly
Merck
Jazz Pharmaceuticals
AbbVie
Flag link:
Eli Lilly, Novartis back a biotech startup boasting 'best of both worlds' protein degraders
Eli Lilly, Novartis back a biotech startup boasting 'best of both worlds' protein degraders
Endpoints
Eli Lilly
Novartis
protein degradation
Amphista
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »